Malignancy outcomes in patients with rheumatoid arthritis treated with abatacept and other disease-modifying antirheumatic drugs: Results from a 10-year international post-marketing study-Reference-Cited by-同舟云学术

Malignancy outcomes in patients with rheumatoid arthritis treated with abatacept and other disease-modifying antirheumatic drugs: Results from a 10-year international post-marketing study

Published:2024-02 Issue: Volume:64 Page:152240
ISSN:0049-0172
Container-title:Seminars in Arthritis and Rheumatism
language:en
Short-container-title:Seminars in Arthritis and Rheumatism

Author:

Simon Teresa A^ORCID,Suissa Samy,Boers Maarten,Hochberg Marc C,Skovron Mary Lou,Askling Johan,Michaud Kaleb,Strangfeld Anja,Pedro Sofia,Frisell Thomas,Meissner Yvette,Dominique Alyssa,Gomez Andres

Funder

Bristol-Myers Squibb Co Summit

Bristol-Myers Squibb

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Rheumatology

Reference37 articles.

1. Selective costimulation modulation using abatacept in patients with active rheumatoid arthritis while receiving etanercept: a randomised clinical trial;Weinblatt;Ann Rheum Dis,2007

2. Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition;Genovese;N Engl J Med,2005

3. Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig;Kremer;N Engl J Med,2003

4. Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: twelve-month results of a phase IIb, double-blind, randomized, placebo-controlled trial;Kremer;Arthritis Rheum,2005

5. Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial;Kremer;Ann Intern Med,2006

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Abatacept versus tumor necrosis factor inhibitors on mortality and medical utilizations in the treatment of rheumatoid arthritis associated interstitial lung disease: a large-scale real-world retrospective cohort study;Clinical and Experimental Medicine;2024-08-12

2. Safety of baricitinib in Japanese patients with rheumatoid arthritis in clinical use: 3-year data of all-case postmarketing surveillance study;Modern Rheumatology;2024-08-09

3. Abatacept and non-melanoma skin cancer in patients with rheumatoid arthritis: a comprehensive evaluation of randomised controlled trials and observational studies;Annals of the Rheumatic Diseases;2023-11-06